Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Asset Writedowns and Impairment (2016 - 2025)

National Healthcare Properties (HLTC) has 11 years of Asset Writedowns and Impairment data on record, last reported at $11.2 million in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 16.6% year-over-year to $11.2 million; the TTM value through Dec 2025 reached $44.9 million, up 80.52%, while the annual FY2025 figure was $44.9 million, 80.52% up from the prior year.
  • Asset Writedowns and Impairment reached $11.2 million in Q4 2025 per HLTC's latest filing, up from $6.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $26.6 million in Q3 2021 and bottomed at $260000.0 in Q1 2024.
  • Average Asset Writedowns and Impairment over 5 years is $8.4 million, with a median of $7.4 million recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 95.13% in 2021, then soared 4476.54% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $7.4 million in 2021, then tumbled by 74.91% to $1.8 million in 2022, then surged by 153.58% to $4.7 million in 2023, then soared by 186.21% to $13.4 million in 2024, then decreased by 16.6% to $11.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $11.2 million in Q4 2025, $6.6 million in Q3 2025, and $15.2 million in Q2 2025.